Sinopharm Group Co Ltd banner

Sinopharm Group Co Ltd
XBER:X2S

Watchlist Manager
Sinopharm Group Co Ltd Logo
Sinopharm Group Co Ltd
XBER:X2S
Watchlist
Price: 2.309 EUR -3.35%
Market Cap: €7.2B

Intrinsic Value

The intrinsic value for Sinopharm Group Co Ltd (X2S) under the Base Case is 9.23 EUR. Compared with the current market price of 2.309 EUR, the stock appears Undervalued by 75% .

X2S Intrinsic Value
9.23 EUR
Undervaluation 75%
Intrinsic Value
Price €2.309
Bear Case
Base Case
Bull Case
Monitor X2S
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €7.38
Get notified when the price drops into your buy zone
Intrinsic Value €9.23
Margin of Safety 20% €7.38
Current Price €2.31
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about X2S?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is X2S valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sinopharm Group Co Ltd.

Explain Valuation
Alternatives to X2S

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one X2S stock?

The intrinsic value for Sinopharm Group Co Ltd (X2S) under the Base Case is 9.23 EUR.

Is X2S stock undervalued or overvalued?

Compared with the current market price of 2.309 EUR, the stock appears Undervalued by 75% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett